 <h1>Asparaginase erwinia chrysanthemi Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of asparaginase erwinia chrysanthemi include:</b> anaphylaxis. <b>Other side effects include:</b> pancreatitis and severe hypersensitivity reaction.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to asparaginase erwinia chrysanthemi: injection powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, asparaginase erwinia chrysanthemi may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking asparaginase erwinia chrysanthemi:</p><p>
<i>More common</i>
</p><ul>
<li>Cough </li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>hives or welts, itching, or rash</li>
<li>hoarseness</li>
<li>irritation</li>
<li>joint pain, stiffness, or swelling</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>redness of the skin</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>tightness in the chest</li>
<li>troubled breathing or swallowing</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>bloating</li>
<li>blurred vision</li>
<li>chills</li>
<li>constipation</li>
<li>dark urine</li>
<li>dry mouth</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>indigestion</li>
<li>loss of appetite</li>
<li>nausea</li>
<li>pains in the chest, groin, or legs, especially calves of the legs</li>
<li>pains in the stomach, side, or abdomen, possibly radiating to the back</li>
<li>seizures</li>
<li>severe headaches of sudden onset</li>
<li>sudden loss of coordination</li>
<li>sudden onset of slurred speech</li>
<li>sudden vision changes</li>
<li>sweating</li>
<li>unexplained weight loss</li>
<li>vomiting</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blood in the urine or stools</li>
<li>bruising</li>
<li>confusion</li>
<li>coughing or vomiting blood</li>
<li>headache</li>
<li>numbness or tingling in the face, arms, or legs</li>
<li>persistent bleeding or oozing from puncture sites, mouth, or nose</li>
<li>red streaks on the skin</li>
<li>swelling, tenderness, or pain at the injection site</li>
<li>trouble speaking, thinking, or walking</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of asparaginase erwinia chrysanthemi may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Diarrhea</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
</ul><p>
<!-- end injection powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to asparaginase erwinia chrysanthemi: injectable powder for injection</i></p><h3>General</h3><p>Most common adverse reactions were systemic hypersensitivity, hyperglycemia, abnormal transaminases, fever, pancreatitis, local reactions, vomiting, nausea, thrombosis, hyperbilirubinemia, abdominal pain/discomfort, and diarrhea.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very common</b> (10% or more): Systemic hypersensitivity (14%)</p>
<p><b>Very rare</b> (less than 0.01%): Anaphylaxis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Pancreatitis, vomiting, nausea, abdominal pain/discomfort, diarrhea, serum amylases increased, serum lipase increased<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Lethargy, somnolence, confusion, dizziness, neurotoxicity, convulsions, headache</p>
<p><b>Rare</b> (less than 0.1%): Dysphasia, dysphagia, CNS depression, coma<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, urticarial, pruritus, erythema, facial edema<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Transaminases abnormal, hyperbilirubinemia, alkaline phosphatase increased, cholesterol increased</p>
<p><b>Rare</b> (less than 0.1%): Hepatic failure</p>
<p><b>Frequency not reported</b>: Hepatomegaly, cholestatic jaundice<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Hypofibrinogenemia, asymptomatic coagulopathy</p>
<p><b>Very rare</b> (less than 0.01%): Neutropenia, febrile neutropenia, thrombocytopenia</p>
<p><b>Frequency not reported</b>: clotting factor decreased, antithrombin III decreased, protein C decreased, protein S decreased, fibrinogen decreased<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Thrombosis, pallor</p>
<p><b>Very rare</b> (less than 0.01%): Hemorrhage</p>
<p><b>Frequency not reported</b>: Hypertension<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperglycemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyperlipidemia</p>
<p><b>Rare</b> (0.01% to 0.1%): Diabetic ketoacidosis</p>
<p><b>Very rare</b> (less than 0.01%): Hyperammonemia<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Local reactions<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fever<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very rare</b> (less than 0.01%): Myalgia, reactive arthritis</p>
<p><b>Frequency not reported</b>: Extremity pain<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very rare</b> (less than 0.01%): Life-threatening sepsis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Erwinaze (asparaginase Erwinia chrysanthemi)." EUSA Pharma, Newtown, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about asparaginase erwinia chrysanthemi</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Asparaginase erwinia chrysanthemi Intramuscular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Erwinaze</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Acute Lymphoblastic Leukemia</li>
<li>Acute Lymphocytic Leukemia</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to asparaginase erwinia chrysanthemi: injectable powder for injection</i></p><h3>General</h3><p>Most common adverse reactions were systemic hypersensitivity, hyperglycemia, abnormal transaminases, fever, pancreatitis, local reactions, vomiting, nausea, thrombosis, hyperbilirubinemia, abdominal pain/discomfort, and diarrhea.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very common</b> (10% or more): Systemic hypersensitivity (14%)</p><p><b>Very rare</b> (less than 0.01%): Anaphylaxis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Pancreatitis, vomiting, nausea, abdominal pain/discomfort, diarrhea, serum amylases increased, serum lipase increased<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Lethargy, somnolence, confusion, dizziness, neurotoxicity, convulsions, headache</p><p><b>Rare</b> (less than 0.1%): Dysphasia, dysphagia, CNS depression, coma<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, urticarial, pruritus, erythema, facial edema<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Transaminases abnormal, hyperbilirubinemia, alkaline phosphatase increased, cholesterol increased</p><p><b>Rare</b> (less than 0.1%): Hepatic failure</p><p><b>Frequency not reported</b>: Hepatomegaly, cholestatic jaundice<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Hypofibrinogenemia, asymptomatic coagulopathy</p><p><b>Very rare</b> (less than 0.01%): Neutropenia, febrile neutropenia, thrombocytopenia</p><p><b>Frequency not reported</b>: clotting factor decreased, antithrombin III decreased, protein C decreased, protein S decreased, fibrinogen decreased<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Thrombosis, pallor</p><p><b>Very rare</b> (less than 0.01%): Hemorrhage</p><p><b>Frequency not reported</b>: Hypertension<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperglycemia</p><p><b>Uncommon</b> (0.1% to 1%): Hyperlipidemia</p><p><b>Rare</b> (0.01% to 0.1%): Diabetic ketoacidosis</p><p><b>Very rare</b> (less than 0.01%): Hyperammonemia<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Local reactions<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fever<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very rare</b> (less than 0.01%): Myalgia, reactive arthritis</p><p><b>Frequency not reported</b>: Extremity pain<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very rare</b> (less than 0.01%): Life-threatening sepsis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Erwinaze (asparaginase Erwinia chrysanthemi)." EUSA Pharma, Newtown, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about asparaginase erwinia chrysanthemi</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Asparaginase erwinia chrysanthemi Intramuscular &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Acute Lymphoblastic Leukemia</li>
<li>Acute Lymphocytic Leukemia</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>